By copying the components of a hormone called glucagon-like peptide-1 (GLP-1), Zepbound can help to reduce hunger and increase feelings of being full, which ends up in weight loss
Moreover, glutamine may limit the inflammatory pathways involved in conditions such as Crohn's disease and ulcerative colitis, helping to relieve symptoms such as digestive discomfort, bloating and abdominal pain
However, the high E-values from our analysis suggest that the likelihood of residual confounders explaining the observed associations is very low, thereby strengthening the potential association in our findings
Scharf E, Zeiler E, Ncube M, Kolbe P, Hwang SY, Goldhamer A, et al
Dulaglutide Dulaglutide (Trulicity) is administered subcutaneously at a maximum dose of 1.5 mg once weekly, and available on license since 2014 for people with T2D as monotherapy in those who cannot take metformin or as add-on treatment in people using oral agents and/or insulin